Literature DB >> 11873873

A polymorphism in the promoter region of the glucocorticoid receptor gene is associated with its transcriptional activity.

Y Ikeda1, T Suehiro, S Tsuzura, T Shiinoki, T Kaneda, Y Kumon, K Hashimoto.   

Abstract

Since glucocorticoid exerts its biological effects by binding to its receptor, the expression efficiency of the glucocorticoid receptor (GR) gene could influence glucocorticoid sensitivity. We found a polymorphism of cytosine/adenine (-22 C/A) in the upstream region of the GR gene. There was no difference in the allelic frequency between normal and type 2 diabetic subjects. The promoter activity determined by luciferase assay was significantly lower in the -22 A allele than in the -22 C allele in both HepG2 (A allele, 4.19 +/- 0.15; C allele, 6.07 +/- 0.27, p < 0.001) and human embryonic kidney 293 cell lines (A allele, 0.93 +/- 0.16; C allele, 1.51 +/- 0.32, p < 0.001). This polymorphism is associated with transcription of the CR gene, which could be related to glucocorticoid sensitivity through an alteration in tissue GR number.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11873873     DOI: 10.1507/endocrj.48.723

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  3 in total

1.  Molecular evidence for a link between the N363S glucocorticoid receptor polymorphism and altered gene expression.

Authors:  Christine M Jewell; John A Cidlowski
Journal:  J Clin Endocrinol Metab       Date:  2007-05-29       Impact factor: 5.958

2.  Impact of glucocorticoid receptor gene (NR3C1) polymorphisms in Turkish patients with metabolic syndrome.

Authors:  Z Kaya; S Caglayan; M Akkiprik; C Aral; G Ozisik; M Ozata; A Ozer
Journal:  J Endocrinol Invest       Date:  2015-11-23       Impact factor: 4.256

3.  Antiemetic effects of granisetron and dexamethasone combination therapy during cisplatin-containing chemotherapy for head and neck cancer: dexamethasone dosage verification trial.

Authors:  Mamoru Tsukuda; Junichi Ishitoya; Yasukazu Mikami; Hideki Matsuda; Hideaki Katori; Choichi Horiuchi; Machiko Kimura; Takahide Taguchi; Takafumi Yoshida; Junichi Nagao; Yasunori Sakuma; Gabor Toth
Journal:  Int J Clin Oncol       Date:  2009-08-25       Impact factor: 3.402

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.